New Study Suggests Targeted Next Generation Sequencing Can Aid in Identification of Menkes Disease
source: pixabay.com

New Study Suggests Targeted Next Generation Sequencing Can Aid in Identification of Menkes Disease

  In a recent press release, biopharmaceutical company Fortress Biotech announced that their study regarding ATP7A targeted next generation DNA sequencing for Menkes disease was published in Molecular Genetics and Metabolism…

Continue Reading New Study Suggests Targeted Next Generation Sequencing Can Aid in Identification of Menkes Disease

Press Release: uniQure Announces First Patient Treated in HOPE-B Pivotal Trial of AMT-061 in Patients with Hemophilia B

Full Patient Enrollment in Study Expected by Year-End 2019 LEXINGTON, Mass. and AMSTERDAM, The Netherlands, Feb. 04, 2019 -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for…

Continue Reading Press Release: uniQure Announces First Patient Treated in HOPE-B Pivotal Trial of AMT-061 in Patients with Hemophilia B

Pulmonary Fibrosis Foundation Launches New PF Health App: Connect Patients to Resources, Providers and Researchers

CHICAGO, July 19, 2018 – The Pulmonary Fibrosis Foundation (PFF) and monARC Bionetworks have partnered to create the mobile app, PF Health, for individuals living with pulmonary fibrosis (PF).  PF Health, now available on Apple App Store (iOS 9.0 or…

Continue Reading Pulmonary Fibrosis Foundation Launches New PF Health App: Connect Patients to Resources, Providers and Researchers

ICYMI: LGS Foundation Press Release- The U.S. Food and Drug Administration (FDA) has approved EPIDIOLEX®

BOHEMIA, N.Y., June 25, 2018 (LGS Foundation) – The LGS Foundation is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved EPIDIOLEX® (cannabidiol / CBD) for the…

Continue Reading ICYMI: LGS Foundation Press Release- The U.S. Food and Drug Administration (FDA) has approved EPIDIOLEX®

American Liver Foundation and Antidote Launch Clinical Trial Matching Tool to Accelerate Liver Disease Research

NEW YORK (PRWEB) MARCH 13, 2018 – The American Liver Foundation (ALF), the nation’s largest patient advocacy organization for people with liver disease, announced today the launch of an online…

Continue Reading American Liver Foundation and Antidote Launch Clinical Trial Matching Tool to Accelerate Liver Disease Research

¡Noticias de última hora! Este nuevo fármaco para el PI parece prometedor

¡NOTICIAS DE ÚLTIMA HORA! Pronto puede haber otro tratamiento para pacientes del IP! La compañía ADMA Biologics, Inc. ha desarrollado una nueva opción de tratamiento, RI-002, para los pacientes que…

Continue Reading ¡Noticias de última hora! Este nuevo fármaco para el PI parece prometedor

Got 2 copies of the F508del mutation? Have you heard about N9115?

Study Title: Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of N91115 to Evaluate Efficacy and Safety in Patients With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation Treated With…

Continue Reading Got 2 copies of the F508del mutation? Have you heard about N9115?
Cystic Fibrosis Patients Vote for Alternatives to Traditional Treatment
Ronnie Sharpe, Founder of CysticLife, performs his therapy even while camping with his wife Amanda.

Cystic Fibrosis Patients Vote for Alternatives to Traditional Treatment

  CYSTIC FIBROSIS PATIENTS VOTE FOR ALTERNATIVES TO TRADITIONAL TREATMENT CysticLife partners with researchers at Mayo Clinic to study if exercise can replace therapy 1x per day Phoenix, AZ: Fed…

Continue Reading Cystic Fibrosis Patients Vote for Alternatives to Traditional Treatment